Press release
Kidney Cancer Drugs Market Growth Accelerates: Strategic Forecast Predicts $10.48 Billion by 2029
Kidney Cancer Drugs Market
Kidney Cancer Drugs Market Size Growth Forecast: What to Expect by 2025?
In the past several years, the market size for kidney cancer drugs has seen robust growth. Expected to rise from $8.2 billion in 2024 to $8.63 billion in 2025, with a compound annual growth rate (CAGR) of 5.1%. The exponential growth during the historic period is due to higher spending on healthcare, a rapidly enlarging elderly population, an increase in pharmaceutical research and development expenditure, and progress in the discovery of cancer drugs.
How Will the Kidney Cancer Drugs Market Size Evolve and Grow by 2029?
In the forthcoming years, the market size for kidney cancer drugs is projected to witness a consistent growth, escalating to $10.48 billion by 2029, with a compound annual growth rate (CAGR) of 5.0%. This surge within the forecast time frame can be credited to factors such as an expanding elderly population, increased spending on healthcare, a rise in strategic partnerships and acquisitions for medicine formulation, and the vast potential of developing economies. Noteworthy trends anticipated for the forecast period comprise embracing 3D technology in drug production and modelling, capital infusion into biomarkers, initiation or acceptance of novel treatment advancements, enhancement of treatment through personalized medicine, investment in artificial intelligence solutions, and affiliations and partnerships with other firms or governmental entities to fast-track the creation of new medicines.
View the full report here:
https://www.thebusinessresearchcompany.com/report/kidney-cancer-drugs-global-market-report
What Drivers Are Propelling the Growth of Kidney Cancer Drugs Market Forward?
One of the main motivators for the progression of the kidney cancer drugs market is the escalating rate of renal cancer. Lifestyles changes, tobacco use, and unhealthy eating practices are few of the elements that aid in the expansion of these renal cancer cells. For example, the American Cancer Society, a health organization located in the U.S., projected in January 2022 that there will be 79,000 new cases of kidney cancer (50,290 men and 28,710 women), and the disease will result in 13,920 deaths (8,960 men and 4,960 women). Most diagnoses fall between the ages of 65 and 74 with the mean age being 64. Kidney cancer is relatively unusual under the age of 45. Consequently, this propels the development of the kidney cancer medications market.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2591&type=smp
Which Emerging Trends Are Transforming the Kidney Cancer Drugs Market in 2025?
In an effort to advance innovation in cancer care, make treatments more affordable, and widen patient access, leading businesses in the kidney cancer drugs market are leveraging technologies such as the development of biosimilars. This pertains to the creation of biological medicines that closely resemble an already authorized reference product, promising equal efficacy, safety, and quality. For example, Amneal Pharmaceuticals Inc., a pharmaceutical company based in the US, introduced RELEUKO (filgrastim-ayow) in November 2022. This biosimilar to Neupogen (filgrastim), engineered by Amneal Pharmaceuticals, is intended for neutropenia treatment, especially for patients undergoing chemotherapy.
What Are the Key Segments in the Kidney Cancer Drugs Market?
The kidney cancer drugs market covered in this report is segmented -
1) By Type: Renal Cell Carcinoma (RCC), Transitional Cell Carcinoma (TCC) Or Urothelial Cell Carcinoma (UCC)
2) By Product: Nexavar (Sorafenib), Sutent (Sunitinib), Afinitor (Everolimus), Votrient (Pazopanib), Avastin (Bevacizumab), Inlyta (Axitinib), Other Products
3) By End Users: Hospitals, Clinics, Research Center, Other End-Users
Subsegments:
1) By Renal Cell Carcinoma (RCC): Targeted Therapies, Immune Checkpoint Inhibitors, Cytokine Therapies
2) By Transitional Cell Carcinoma (TCC) Or Urothelial Cell Carcinoma (UCC): Chemotherapy Agents, Immunotherapy Agents, Antibody-Drug Conjugates (ADCs)
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=2591&type=smp
Who Are the Key Players Shaping the Kidney Cancer Drugs Market's Competitive Landscape?
Major companies operating in the kidney cancer drugs market include Pfizer Inc., Novartis AG, ExelixisInc., F. Hoffmann-La Roche AG, Bristol Myers Squibb Company, Bayer AG, Merck & Co., Inc., EUSA Pharma Inc., UroGen Pharma Ltd., Natco Pharma, CStone Pharma, CARsgen Therapeutics, JW Therapeutics, BeiGene, Takeda Pharmaceuticals, Astellas Pharma Inc, Otsuka Pharmaceutical Co., Ltd, Daiichi Pharmaceutical and Sankyo, AstraZeneca plc, GlaxoSmithKline plc, Amgen Inc ., Biocon Ltd, Rani Therapeutics, Eli Lilly and Company, Abbvie, Johnson & Johnson, Sanofi, Biogen Inc, AVEO Oncology, Teva Pharmaceutical Industries Ltd., Kitov Pharma Limited, CureTech Ltd., Neopharma
What Geographic Markets Are Powering Growth in the Kidney Cancer Drugs Market?
North America was the largest region in the kidney cancer drugs market in 2024. Middle East is expected to be the fastest-growing region in the global kidney cancer drugs market share during the forecast period. The regions covered in the kidney cancer drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2591
This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas - +1 310-496-7795 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Kidney Cancer Drugs Market Growth Accelerates: Strategic Forecast Predicts $10.48 Billion by 2029 here
News-ID: 4104225 • Views: …
More Releases from The Business Research Company
Butter Powder Market Overview: Major Segments, Strategic Developments, and Leadi …
The butter powder market is poised for significant expansion over the coming years, driven by evolving consumer preferences and growing applications across the food industry. With increasing incorporation into various products and rising interest in specialty varieties, this market is set to experience sustained growth and innovation through 2030.
Butter Powder Market Size and Growth Expectations Through 2030
The butter powder market size is projected to reach $3.08 billion by…
Emerging Sub-Segments Transforming the Brewer's Yeast Market Landscape
The brewer's yeast market is on the verge of remarkable growth, driven by evolving consumer demands and expanding applications across various industries. As nutritional preferences shift and innovation accelerates, this sector is set to achieve significant milestones by 2030. Let's explore the current market valuation, key players, emerging trends, and segment dynamics shaping the brewer's yeast industry.
Projected Market Value and Expansion of the Brewer's Yeast Market
The brewer's yeast…
Top Players and Market Competition in the Bourbon Spirits Industry
The bourbon spirits market is positioned for notable expansion over the coming years, driven by evolving consumer tastes and increasing global interest. As the industry adapts to new trends and capitalizes on innovative marketing strategies, the sector is expected to experience steady growth that reflects both traditional appeal and modern preferences.
Projected Growth of the Bourbon Spirits Market Through 2030
The bourbon spirits market is anticipated to reach a value…
Black Alkaline Water Market Analysis: Major Segments, Strategic Developments, an …
The black alkaline water market is gaining significant attention as consumers increasingly seek functional and health-focused hydration options. With a variety of wellness trends influencing buying decisions, this sector is poised for remarkable expansion in the coming years. Let's delve into the market's projected size, key players, emerging trends, and detailed segment insights to better understand its promising future.
Forecasted Market Value and Growth Trajectory of the Black Alkaline Water Market…
More Releases for Kidney
Chronic Kidney Diseases Fueling Kidney Stone Retrieval Device Growth Driving Mar …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Kidney Stone Retrieval Devices Market Size By 2025?
In recent times, the market size for kidney stone retrieval devices has seen consistent growth. The market, which is projected to increase from $2.84 billion in 2024 to $2.96 billion in 2025, forecasts a compound annual growth…
Wearable Artificial Kidney Market Development Trajectory through 2031 Dutch Kidn …
"[New York, December 2024] The Wearable Artificial Kidney represents a groundbreaking innovation in nephrology that combines advanced biomedical engineering with portable technology. Designed to continuously filter waste from the blood, this device caters primarily to patients with chronic kidney disease. As renal health issues become more prevalent globally, the relevance of the Wearable Artificial Kidney lies in its potential to enhance patient quality of life, providing a more convenient and…
Kidney Dialysis Market Share Kidney Dialysis Market
According to Ameco Research 'Kidney Dialysis Market report, the analysts took this into account when estimating the Kidney Dialysis Market size and CAGR for the respective industry. The report's author has thoroughly examined the market and concluded that the Kidney Dialysis Market 's growth will level off in the coming years. In addition to that, the prominent qualitative information added in the report includes Kidney Dialysis Market trends, segmentation, key…
Kidney Health Journey: Polycystic Kidney Disease Drug Pipeline Landscape (2023-2 …
Market Outlook:
The Polycystic Kidney Disease (PKD) drug pipeline landscape is poised for noteworthy advancements, offering a positive outlook for those navigating the complex journey of kidney health. As PKD poses a significant global health burden, the market outlook reflects a pressing need for innovative pharmaceutical interventions to address the challenges associated with this genetic disorder. With ongoing research and development efforts, the PKD drug pipeline is positioned to bring…
Kidney Balloon Market Growth Drives By Rising Prevalence of Kidney Stone and Oth …
Demand Analysis of Kidney Balloon Market Overview:
Kidney Balloon Market is predicted to grow at a moderate CAGR of 5.2% during the forecast period covering 2022 to 2029. Kidney Balloon Market share is estimated to reach a value of nearly US$ 2.50 Billion by 2029.
The "Kidney Balloon Market" think about 2022, the industry landscape is secured from driving factors to upstream markets and the by and large state of the market.…
Artificial Kidney Market Report 2018: Segmentation by Type (Wearable Artificial …
Global Artificial Kidney market research report provides company profile for Medtronic, DaVita, Merit Medical Systems, NIPRO Medical Corporation, Nikkiso, B. Braun Melsungen AG, Kawasumi Laboratories, Fresenius, Baxter, Asahi Kasei Medical, Xcorporeal and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for…
